【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 11
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q3 2013 15
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q3 2013 15
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q3 2013 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q3 2013 18
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q3 2013 19
2.4.1 Shoppers Drug Mart Receives Ontario Court Approval for Its Acquisition by Loblaw for US$11.93 Billion 19
2.4.2 Amgen Completes Tender Offer to Acquire Onyx Pharma for up To US$10.4 Billion 21
2.4.3 Community Health Systems to Acquire Health Management Associates for up to US$7.6 Billion 22
2.4.4 Fresenius to Acquire 43 Hospitals from Rhon-Klinikum for US$4.1 Billion 23
2.4.5 Tenet Healthcare Prices Private Placement of Notes Due 2022 for US$2.8 Billion 24
3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 25
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q3 2013 25
3.1.1 Top M&A Deals in Q3 2013 26
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q3 2012 – Q3 2013 27
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q3 2013 29
3.2.1 Top Initial Public Offerings in Q3 2013 31
3.2.2 Top Secondary Offerings in Q3 2013 31
3.2.3 Top PIPE Deals in Q3 2013 31
3.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q3 2012-Q3 2013 32
3.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q3 2012 – Q3 2013 33
3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q3 2013 35
3.3.1 Top Venture Financing Deals in Q3 2013 36
3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q3 2013 37
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q3 2013 38
3.3.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q3 2012 – Q3 2013 39
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Last Four Quarters 41
3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q3 2012 – Q3 2013 43
3.4 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q3 2013 44
3.4.1 Top Private Equity Deals in Q3 2013 45
3.4.2 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q3 2012 – Q3 2013 46
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q3 2013 48
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q3 2013 48
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q3 2012 – Q3 2013 50
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q3 2013 52
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q3 2013 54
4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q3 2013 54
4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q3 2013 55
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q3 2012 – Q3 2013 56
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q3 2012 – Q3 2013 58
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q3 2012 – Q3 2013 59
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q3 2012 – Q3 2013 61
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q3 2013 63
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q3 2013 63
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q3 2012 – Q3 2013 65
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q3 2013 67
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q3 2013 67
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q3 2013 68
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q3 2012 – Q3 2013 69
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q3 2012 – Q3 2013 71
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q3 2012 – Q3 2013 73
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q3 2012 – Q3 2013 74
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q3 2012 – Q3 2013 76
6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 78
6.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q3 2012 – Q3 2013 78
6.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q3 2012 – Q3 2013 80
6.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q3 2012 – Q3 2013 82
6.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q3 2012 – Q3 2013 84
6.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q3 2012 – Q3 2013 86
6.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q3 2012 – Q3 2013 88
6.7 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q3 2012 – Q3 2013 90
7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 92
7.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q3 2013 92
7.1.1 Oncology – Deals of the Quarter 94
7.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q3 2013 96
7.2.1 Central Nervous System – Deals of the Quarter 98
7.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q3 2013 101
7.3.1 Infectious Disease – Deals of the Quarter 103
7.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q3 2013 105
7.4.1 Immunology – Deals of the Quarter 107
7.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q3 2013 108
7.5.1 Metabolic Disorders – Deals of the Quarter 110
7.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q3 2013 112
7.6.1 Cardiovascular – Deals of the Quarter 114
7.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q3 2013 116
7.7.1 Gastrointestinal – Deals of the Quarter 118
7.8 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q3 2013 119
7.8.1 Dermatology – Deals of the Quarter 121
7.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q3 2013 122
7.9.1 Respiratory – Deals of the Quarter 124
7.10 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q3 2013 126
7.10.1 Ophthalmology – Deals of the Quarter 128
8 Deal Summary by Geography 130
8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q3 2013 130
8.1.1 North America – Deals of the Quarter 132
8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q3 2013 135
8.2.1 Europe – Deals of the Quarter 137
8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q3 2013 139
8.3.1 Asia-Pacific – Deals of the Quarter 141
8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q3 2013 144
8.4.1 Rest of the World – Deals of the Quarter 146
9 Pharmaceuticals & Healthcare, Global, Top Advisors 148
9.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Last One Year 148
9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Last One Year 150
10 Appendix 152
11 Further Information 156
11.1 Methodology 156
11.2 About GlobalData 157
11.3 Disclosure information 158
11.4 Disclaimer 158
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向（四半期別）：Q3 2013■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2013
■ 発行日：2013年11月30日
■ 調査会社：GlobalData
■ 商品コード：GDATA403162973
■ 調査対象地域：グローバル
- 永久磁石同期電動機（PMSM）の世界市場This report estimates the Permanent Magnet Synchronous Motor (PMSM) market in terms of value in USD million. The market has been segmented into regions, and further split into countries. The use of energy-efficient motors and demand for low power consumption ones motors across the globe would drive the PMSM market. The PMSM is a rotating electric machine where the stator is a classic three-phase s …
- 世界の電磁鋼市場2015The Global Electrical Steel Industry Report 2015 is a professional and in-depth study on the current state of the Electrical Steel industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Electrical Steel market analysis is provided for the international markets including development trends, competitive la …
- 圧力モニタリングの世界市場分析：製品別（血圧、肺圧、眼内圧、頭蓋内圧）、手順別（非侵襲性、侵襲性）、用途別、エンドユーザー別、セグメント予測、2014-2025The global pressure monitoring market is expected to reach USD 11.9 billion by 2025, according to a new report by Grand View Research, Inc. Pressure fluctuations in vital parts of the body often lead to chronic diseases such as glaucoma, cardiac disorders, and respiratory disorders. This has led to high demand for pressure monitoring devices.According to the American Heart Association, 77.9 millio …
- 民間航空機用座席の世界市場2019-2023Global Commercial Aircraft Seating Market: About this market Technavio’s commercial aircraft seating market analysis considers sales from economy class, business class, premium economy class, and first-class. Our analysis also considers the sales of commercial aircraft seating in APAC, Europe, North America, South America, and MEA. In 2018, economy class segment had a significant market share, and …
- 放射線サーベイメータの世界市場About Radiation Survey MetersRadiation survey meters are portable radiation detection and monitoring instruments that are used to measure external radiation hazards. These instruments are designed to be handheld and display count rate of radiations. Technavio’s analysts forecast the global radiation survey meters market to grow at a CAGR of 5.14% during the period 2017-2021. [Covered in this repor …
- スマートガラスの世界市場分析：製品別（エレクトロクロミック、PDLC、SPD、サーモクロミック）、用途別（建築、運輸、消費者家電）、輸送別、地域別、セグメント予測、2014-2025The global smart glass market size is expected to reach USD 9.98 billion by 2025, according to a new report by Grand View Research, Inc. The growing glazing area in commercial and residential buildings is expected to impact the market positively over the next few years. Architects are suggesting the use of smart technology for new buildings, which is expected to drive smart glass demand in the arc …
- 油井管(OCTG)の世界市場About OCTG OCTG is a set of equipment used in the drilling and extraction of on-shore and off-shore oil and gas. OCTG consists of drilling pipes, casing pipes, tubing pipes, and other line pipes used in the production and transportation of oil from wells to refineries. Casing pipes are placed at a wellhead to extract oil during the drilling process. Tubing pipes are inserted in the well after the …
- ポリグリセリンの世界市場：製品別（PG-2、3、4、6、10）、アプリケーション別（飲食料品、医薬品、パーソナルケア）、地域別、セグメント予測The global polyglycerol market size is expected to reach at USD 3.83 billion by 2025 expanding at a CAGR of 9.0% during the forecast period, according to a new report by Grand View Research, Inc. Polyglyceryl-3 diisostearate, polyglyceryl-3 dimer dilinoleate, and polyglyceryl-3 ricinoleate are some of the key polyglycerol 3 esters. Polyglycerol esters are plant/vegetable-derived, which makes them …
- 分子細胞遺伝学の世界市場分析：技術別（FISHおよびCGH）、用途別（遺伝的疾患、がん、オーダメイド医療）、セグメント予測Global molecular cytogenetics market is expected to reach nearly USD 3.6 billion by 2022, according to a new report by Grand View Research, Inc. Increasing instances of both, chromosomal anomalies implicated in genetic disorders and cancer, coupled with technological advancements in the molecular cytogenetic techniques is expected to positively reinforce the market growth. Technological advancemen …
- 世界のシンチレータ市場予測と分析：無機シンチレータ、有機シンチレータScintillators are luminescent materials, which re-emit part of the absorbed energy in the form of light. The emission can be of different types: fluorescence (prompt), delayed fluorescence and phosphorescence (delayed with different wavelength). The radiation detection and monitoring has witnessed various technological advancements in recent years. This advancement has led to the rise in the marke …
- Reliance Industries Limited：石油・ガスバリューチェーン分析レポート2013Reliance Industries Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Reliance Industries Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Reliance Industries Limited”. The report provides key information relating to oil and gas assets of the company along with its operations across the value c …
- Exillon Energy Plc：石油・ガスの開発・生産動向及びコスト分析- 2012Exillon Energy Plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Exillon Energy Plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key o …
- 機械状態監視装置の世界市場：振動モニタリング装置、サーモグラフィー、超音波放出装置、潤滑油分析装置、腐食モニタリング装置、電流徴候解析装置などMachine condition monitoring is the best way of maintenance to meet requirements of production. It is the process of monitoring the health of a machine with the intent to predict mechanical wear and failure. Machine condition monitoring is a part of predictive maintenance technique. Machine condition monitoring market has a broad scope in industry. This market is important as it provide condition …
- 世界の航空宇宙分野向けロボット市場動向（2012-2016）TechNavio's analysts forecast the Global Aerospace Service Robotics market to grow at a CAGR of 24.11 percent over the period 2012-2016. One of the key factors contributing to this market growth is the development of telerobotics for space. The Global Aerospace Service Robotics market has also been witnessing an increase in the demand for unmanned aerial vehicles. However, rapid technological chan …
- 尿道カテーテルの世界市場分析：製品別（断続的カテーテル、フォーリー/留置カテーテル、外部カテーテル）、用途別（良性前立腺肥大、尿失禁、その他）、セグメント予測、2013-2024The global urinary catheters market is expected to reach USD 5.51 billion by 2024, according to a new report by Grand View Research, Inc. The key contributors for the expansion of the market include the rising incidence of urinary disorders, growing elderly population, and technological advancements pertaining to the relevant devices. These catheters have application in patients suffering from uri …
